Eli Lilly obesity therapy succeeds in late-stage trials for sleep disorder

Eli Lilly (LLY) stock gains as the company's weight loss therapy, tirzepatide, achieved positive results in Phase 3 trials for obesity and sleep apnea. Read more here. Read More

Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank

Before market open, Eli Lilly announced that its molecule tirzepatide had achieved its primary endpoints in a set of phase 3 clinical trials. The studies aimed to judge its efficacy in treating ... Read More

Lilly’s weight-loss drug reduces sleep apnea severity in late-stage trials

Eli Lilly (LLY.N), opens new tab said on Wednesday its weight-loss drug helped reduce episodes of irregular breathing associated with a common sleep-related disorder in two late-stage trials, paving ... Read More

Eli Lilly launches website to help patients get weight loss drugs

Drugmaker Eli Lilly announced on Thursday a new website that will allow patients to get a weight loss ... It comes less than two months after the Food and Drug Administration approved Lilly ... Read More

Eli Lilly's new website to help patients access weight-loss medicine

The new website launched two months after the Food ... down the wrong tube). But Eli Lilly says its weight-loss drug's benefits outweigh the risks for some patients. Trials indicated that those ... Read More

Eli Lilly Warns That 2 Insulin Products Will Be in Short Supply

Eli Lilly Warns That 2 Insulin Products Will Be in Short Supply By Ernie Mundell and Carole Tanzer Miller HealthDay Reporters MONDAY, March 25, 2024 (HealthDay News) -- Drugmaker Eli Lilly & Co is ... Read More

Move over, Mounjaro: New Eli Lilly drug lost patients 24 percent of their weight in trials

A new Eli Lilly experimental ... a clinical trial, CNBC reported. The phase two trial saw patients who took a 12-milligram dose of retatrutide lose 17.5 percent of their weight after 24 weeks ... Read More

Health News

April 18 (UPI) -- Scotland's only gender clinic has paused hormone treatment for patients younger ... in two company trials, drug maker Eli Lilly announced Wednesday. Health News // 1 day ago ... Read More

Eli Lilly and Company (LLY)

In this article, we discuss the 13 best low volatility stocks to buy according to hedge funds. To skip the detailed analysis of the current market conditions, go directly to the 5 Best Low ... Read More

Eli Lilly and Co

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ... Read More

Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugs

Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound. The drugmaker said Thursday it will use ... Read More